• Home
  • About Us
  • Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Medical And Healthcare DiaMedica Initiates Type 1 Diabetes Study; Announces Preliminary Results

DiaMedica Initiates Type 1 Diabetes Study; Announces Preliminary Results

Posted on July 8, 2010 Written by Annalyn Frame

WINNIPEG, MANITOBA–(Marketwire – July 8, 2010) – DiaMedica Inc., (TSX VENTURE:DMA) today announces that it has initiated a Type 1 diabetes program. The recently announced Sanomune acquisition allows DiaMedica to expand into Type 1 diabetes. The initiation of this program is based on encouraging preclinical results with DM-99, a naturally occurring protein that the company has previously shown to have clinical efficacy for Type 2 diabetes.

In the study, animals were injected with streptozotocin, a naturally occurring compound known to be toxic to beta cells, to mimic the disease. A week after this streptozotocin treatment, animals were injected twice daily with DM-99 for a period of 21 days at which time fasting blood glucose measurements were taken. Animals treated with DM-99 had a statistically significant 68% (p=0.05) reduction in fasting blood glucose compared to untreated animals. Furthermore, the DM-99 treatment resulted in a positive reduction in total glucose as measured by an oral glucose tolerance test.

“Initial results from this study show that DM-99 was able to reduce fasting blood glucose, an indication that new beta cells may be created or that existing beta cells are being protected from the streptozotocin insult,” stated Rick Pauls, President and CEO of DiaMedica. “The final results and analysis of DM-99 on the direct effects upon the pancreas (insulin production and beta cell proliferation) is expected during the summer of 2010.”

About Type 1 Diabetes

According to the Juvenile Diabetes Research Foundation, as many as 3 million Americans may have Type 1diabetes, an autoimmune disease that strikes children and adults suddenly and can be fatal. In Type 1 diabetes, the host’s own immune system destroys beta cells in the pancreas that normally control blood sugar level by producing insulin. Currently, patients with Type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times each day, or use a pump daily to control blood sugar levels. Even with intensive care, insulin is not a cure for diabetes, nor does it completely prevent the eventual and devastating complications of diabetes, which may include kidney failure, blindness, heart disease, stroke, and amputation.

About DiaMedica

DiaMedica is a biopharmaceutical company focused on developing novel treatments for diabetes and neurological disorders. The Company’s Type 2 diabetes program is based on a critical liver nerve signaling mechanism involved in enhancing insulin sensitivity after meal consumption. Two of DiaMedica’s products have previously demonstrated human efficacy in lowering blood sugar levels in people diagnosed with Type 2 diabetes based on this novel nerve signaling mechanism.

DiaMedica has expanded its DM-199 recombinant protein program into neurological and autoimmune disorders. The Company has demonstrated that DM-99, the naturally occurring form of DM-199, confers neural protection (protects brain cells) and triggers neural stem cell proliferation (creates brain cells) for the treatment of numerous neurological disorders including Alzheimer’s disease. DiaMedica is listed on the TSX Venture Exchange under the trading symbol “DMA”.

For further information please visit www.diamedica.com.

Caution Regarding Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable Canadian provincial securities legislation (collectively, the “forward-looking statements“). These forward-looking statements relate to, among other things, DiaMedica’s objectives, goals, targets, strategies, intentions, plans, beliefs, estimates and outlook, and can, in some cases, be identified by the use of words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “may” and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Specifically, this press release contains forward-looking statements regarding matters such as, but not limited to, the anticipated use of proceeds from the Offering, management’s assessment of DiaMedica’s future plans, information with respect to the advancement of DiaMedica’s research and development programs, and DiaMedica’s other estimates and expectations. These statements reflect management’s current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from these expectations include, among other things: uncertainties and risks related to our research and development programs, the availability of additional financing, risks and uncertainties relating to the anticipated use of proceeds, changes in debt and equity markets, uncertainties related to clinical trials and product development, rapid technological change, uncertainties related to forecasts, competition, potential product liability, additional financing requirements and access to capital, unproven markets, the cost and supply of raw materials, management of growth, effects of insurers’ willingness to pay for products, risks related to regulatory matters and risks related to intellectual property matters. Additional information about these factors and about the material factors or assumptions underlying such forward-looking statements may be found in the body of this news release, as well as under the heading “Risk Factors” contained in DiaMedica’s 2009 annual information form. DiaMedica cautions that the foregoing list of important factors that may affect future results is not exhaustive. When relying on DiaMedica’s forward-looking statements to make decisions with respect to DiaMedica, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Such forward-looking statements are based on a number of estimates and assumptions, which may prove to be incorrect, including, but not limited to, assumptions regarding the availability of additional financing for research and development companies, and general business and economic conditions.These risks and uncertainties should be considered carefully and investors and others should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, DiaMedica cannot provide assurance that actual results will be consistent with these forward-looking statements. DiaMedica undertakes no obligation to update or revise any forward-looking statement. Additional risk factors, factors which could cause actual results to differ materially from expectations, and assumptions relating specifically to our acquisition of Sanomune may be found in our press releases dated February 18, 2010 and April 20, 2010.

Filed Under: Medical And Healthcare

Recent News

  • DarioHealth Strikes Gold with Major Health Plan Deal, Boosting Revenue and Market Position March 18, 2025
  • Texas Patients Left in the Dark? This Bill Aims to Change That March 17, 2025
  • Health Insurance Denied Your Claim? This Company is Stepping In to Pay for Your Care March 6, 2025
  • Big Changes in Atlanta—Peach State Health Plan Invests in a Major Housing Overhaul March 6, 2025
  • Wellmark Joins Forces with Evio Pharmacy to Make Medications More Affordable March 6, 2025
  • Raintree Systems Snaps Up Yoomi Health in a Bold AI Move for Rehab Therapy January 24, 2025
  • Medicare’s New $2,000 Cap: How Enrollees Will Save Thousands in 2025 January 16, 2025
  • Breaking Barriers: How ‘Ohana Health Plan is Reshaping Care for Hawaii’s Most Vulnerable January 16, 2025
  • Blue Shield of California Provides Crucial Support to Wildfire Victims January 9, 2025
  • New CFPB Rule Removes Medical Bills from Credit Reports, Boosting Millions’ Scores January 7, 2025

Search Our Site

Categories

  • AARP
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • CIGNA HealthCare
  • COVID-19
  • Facilities And Providers
  • FDA
  • Health Clinics
  • Healthcare Companies
  • Healthcare Plan News
  • Humana
  • MedBasics
  • Medical And Healthcare
  • Medical Malpractice
  • Medicare
  • Senior News
  • The SCOOTER Store

Our Partners

Portal of Dallas
Auto News Review
OSS News Review
Holly Bushes
Rose Bushes
SatelliteDish.Net
I Go Cars
Bad School Photos
Canonical Tag
Check A Domain
Idaho Resorts
iWannaBeFamous
Mabank Online
Stockyards
TravelXL

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Achieve Your Weight Goals with Advanced Thermogenic with NMN
  • Affordable Health Insurance
  • Anavar: A Deep Dive into Athletic Benefits, Potential Side Effects, and Weight Loss Applications
    • Anavar Cycle: Benefits, Dosages, and Side Effects
      • Anavar Cycle: Benefits, Dosages, and Side Effects
    • Deca Durabolin vs Anavar: Comparing Performance Enhancers
  • B12 Elite Elixir: Vitalizing Your Health and Energy Levels
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Disclaimer
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Elite Health Online Dual Stack approach: Unlock your weight loss potential
  • Elite Thermogenic Formula: A Game-Changer in Weight Management and Metabolic Health
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Harnessing the Power of HGH for Vitality and Youthfulness
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • Hormone Replacement Therapy
    • Harmonizing Body and Spirit: Navigating through Hormone Replacement Therapy
    • Hormone Replacement Therapy (HRT) – A Double-Edged Sword
    • Hormone Replacement Therapy (HRT): A Guide to Rebalancing Hormones
    • Hormone Replacement Therapy (HRT): Balancing the Benefits, Side Effects, and Menopausal Relief
    • Hormone Replacement Therapy: Benefits & Considerations
  • Hot ROCS: The Ultimate Solution for Enhanced Energy and Metabolism
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Device CROs: The Role in Research and Development
  • Medical Malpractice
  • Medical Research Consultants
  • Menopause and HRT
  • Mounjaro (Tirzepatide): A Breakthrough in Diabetes and Obesity Management
  • Nicotinamide Adenine Dinucleotide – Unleashing Vital Molecule Power for Optimal health
    • Unlocking the Power of NMN in Our Advanced Thermogenic and NMN Formula
  • Oxytocin Benefits
    • Oxytocin: The Love Hormone Decoded
    • Oxytocin: The Love Hormone’s Role in Bonding and Beyond
  • Oxytocin Benefits and Hormone Therapy
  • Peptides: The Future of Health and Wellness
    • Semax Peptide – A Glimpse into Nootropic Advancements
  • Personal Lubricants for Women – Liven Up Your Life!
  • Phentermine: Benefits, Usage, and Potential Side Effects
  • Privacy Policy
  • Private Health Insurance Plans
  • Rapamycin, the anti-aging marvel and its multidimensional health benefits
    • Rapamycin: The Anti-Aging Wonder Drug
  • Rhesus Negative
  • Self Employed Health Insurance
  • Semaglutide: A Safe and Effective Alternative to Surgical Weight Loss
    • Semaglutide and its Weight Loss Benefits
    • Semaglutide: A Revolutionary Treatment Explored
    • Semaglutide: Bridging Diabetes Treatment and Weight Loss While Managing Side Effects
    • Semaglutide: Revolutionizing Weight Loss and Diabetes Management
    • Semaglutide: Transforming Weight Management and Glycemic Control
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • Terms of Use
  • Testosterone Replacement Therapy Insights
    • Exploring the HCG Diet: Unveiling a Unique Pathway Towards Weight Management
    • Testosterone for Females: Balancing Health & Wellness
      • Testosterone for Females: Exploration of Hormonal Balance and Health
    • Testosterone Replacement Therapy (TRT): A Comprehensive Guide
    • Unlocking the Pivotal Role of Testosterone in Holistic Wellbeing
  • Testosterone Therapy: Weighing the Benefits, Risks, and Identifying Symptoms
    • The Vital Role of Testosterone in Health & Well-being
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Marvels and Misgivings of Rapamycin: A Glimpse into Anti-aging and Longevity Benefits
  • The Use of Post Cycle Therapy Supplements
  • Timeless Beauty Med Spa: Elevating Skincare in Dallas, Texas
    • Achieve Your Body Goals with Emsculpt Neo: Now Available at Timeless Beauty Med Spa in Dallas, Texas
    • The Ultimate Guide to Facials: A Path to Radiant Skin
  • Travel Health Insurance
  • Ultimate Guide for Anavar Cycles
  • Understanding Metformin: Benefits and Insights
    • Metformin: A Pillar of Hope in Weight Loss Journeys
    • Metformin: The Multifaceted Medication for Modern Health Challenges
  • Understanding Nandrolone: Benefits and Uses
    • Demystifying Nandrolone: Uses, Potential Benefits, and Considerations
    • Nandrolone for Joint Pain: Efficacy, Benefits, and Considerations
    • Nandrolone: From Muscle Building to Therapeutic Uses and Side Effects
  • Unleash your Potential with Nandrolone & Deca Durabolin
  • Unleashing Glutathione’s Power: The Key to Anti-Aging and Health
  • Unlocking Testosterone’s Power: A Comprehensive Guide to Better Health
  • Winstrol – Beyond the World of Bodybuilding
    • Unlocking the Potential of Winstrol: Dosage, Benefits, and Risks

Copyright © 2025 - Privacy Policy - Terms of Use - Disclaimer